Explore

Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy to Advance AI-Driven Treatment

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy to Advance AI-Driven Treatment

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy to Advance AI-Driven Treatment
Trendline Trendline
Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development

Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development

Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement
Trendline Trendline
Cellular Intelligence Partners with Novo Nordisk for Parkinson's Cell Therapy

Cellular Intelligence Partners with Novo Nordisk for Parkinson's Cell Therapy

Cellular Intelligence Partners with Novo Nordisk for Parkinson's Cell Therapy
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development
Trendline Trendline
iOrganBio Appoints Jessica Owens to Board, Enhancing AI-Driven Cell Manufacturing

iOrganBio Appoints Jessica Owens to Board, Enhancing AI-Driven Cell Manufacturing

iOrganBio Appoints Jessica Owens to Board, Enhancing AI-Driven Cell Manufacturing
Trendline Trendline
Trisk Bio and NanoMosaic Partner to Enhance AAV Analytics with Tessie Platform

Trisk Bio and NanoMosaic Partner to Enhance AAV Analytics with Tessie Platform

Trisk Bio and NanoMosaic Partner to Enhance AAV Analytics with Tessie Platform
Trendline Trendline
Zai Lab Gains FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Neuroendocrine Carcinomas

Zai Lab Gains FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Neuroendocrine Carcinomas

Zai Lab Gains FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Neuroendocrine Carcinomas
Trendline Trendline
Rznomics Secures FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma Treatment

Rznomics Secures FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma Treatment

Rznomics Secures FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma Treatment
Trendline Trendline
Rznomics Receives FDA RMAT Designation for RZ-001 in Liver Cancer Treatment

Rznomics Receives FDA RMAT Designation for RZ-001 in Liver Cancer Treatment

Rznomics Receives FDA RMAT Designation for RZ-001 in Liver Cancer Treatment
Trendline Trendline
Vistagen Completes Phase 3 Study for Fasedienol in Social Anxiety Disorder

Vistagen Completes Phase 3 Study for Fasedienol in Social Anxiety Disorder

Vistagen Completes Phase 3 Study for Fasedienol in Social Anxiety Disorder
Trendline Trendline
Whoop to Introduce On-Demand Clinician Access for U.S. Users with New Features

Whoop to Introduce On-Demand Clinician Access for U.S. Users with New Features

Whoop to Introduce On-Demand Clinician Access for U.S. Users with New Features